Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
22,3 USD | -0,80% | +0,68% | +509,29% |
01/04 | LANDOS BIOPHARMA, INC. : HC Wainwright verlaagt advies naar Neutraal | ZM |
25/03 | Deals van de dag - Fusies en overnames | RE |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 69,71 mln. 65,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -26 mln. -24,4 mln. | Nettowinst (verlies) 2025 * | -46 mln. -43,18 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 72,5 mln. 68,05 mln. | Nettoliquiditeiten 2025 * | 30 mln. 28,16 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-9,49
x | K/w-verhouding 2025 * |
-13,2
x | Werknemers | 19 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 42,54% |
1 dag | -0,80% | ||
1 week | +0,68% | ||
1 maand | +3,82% | ||
3 maanden | +313,73% | ||
6 maanden | +457,50% | ||
Lopend jaar | +509,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Oakes
CEO | Chief Executive Officer | 56 | 21-06-22 |
Claudia Lopez
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-23 |
Dawn Louro
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 57 | 01-09-17 | |
Tim Mayleben
BRD | Director/Board Member | 63 | 13-05-21 |
Alka Batycky
BRD | Director/Board Member | 54 | 30-05-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 22,3 | -0,80% | 1 677 |
29-04-24 | 22,48 | +0,76% | 3 969 |
26-04-24 | 22,31 | -0,80% | 14 876 |
25-04-24 | 22,49 | +1,40% | 3 928 |
24-04-24 | 22,18 | +0,13% | 9 082 |
uitgestelde koers Nasdaq, 30 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+509,29% | 69,71 mln. | |
+0,17% | 42,19 mld. | |
+10,92% | 42,24 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+5,23% | 24,63 mld. | |
-24,79% | 18,2 mld. | |
+26,69% | 12,01 mld. | |
-3,13% | 11,76 mld. | |
+6,57% | 10,4 mld. |